Related Experiment Videos
Chemoimmunotherapeutical studies on Dalton's lymphoma with cis-platin
Polish Journal of Pharmacology and Pharmacy
|July 1, 1985
Summary
Cis-platin (cis-dichlorodiamine platinum II) treatment enhances the host cellular immune system in mice. This study investigated its effect on Dalton
Area of Science:
- Immunology
- Cancer Research
- Pharmacology
Background:
- Dalton's lymphoma is a type of cancer studied in animal models.
- Cis-platin (cis-dichlorodiamine platinum II) is a chemotherapy drug.
- Understanding the immunomodulatory effects of chemotherapy is crucial for cancer treatment.
Purpose of the Study:
- To investigate the effect of cis-platin on Dalton's lymphoma in mice.
- To assess cis-platin's impact on the host cellular immune system.
- To evaluate the development of immunity following cis-platin treatment.
Main Methods:
- Studied cis-platin's effect on Dalton's lymphoma in syngeneic DBA and allogeneic Swiss white mice.
- Immunized normal mice with cis-platin incubated cells and challenged them to assess immunity.
- Used in vitro capillary cell migration inhibition assay to measure cell-mediated immunity against tumor antigen.
Main Results:
- Cis-platin treatment demonstrated a specific enhancement of the host cellular immune system.
- Cell-mediated immunity was investigated in both DBA and Swiss white mice.
- The study observed specific immune responses following cis-platin administration.
Conclusions:
- Cis-platin treatment can specifically enhance the cellular immune system in mice.
- This enhancement may contribute to the anti-tumor effects of cis-platin.
- Further research is warranted to explore the clinical implications of cis-platin's immunomodulatory properties.